Clinical Trial Update: Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing extended-release versus immediate-release tacrolimus in patients with renal allograft failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allosensitization
• Renal Transplant Failure

Drugs mentioned

• Advagraf (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Imperial College Healthcare NHS Trust | Conditions: Kidney Transplant Failure, Allosensitization | Phase 4 | Status: TERMINATED